Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$622,434
+$108,260 QoQ
Shares Held
2,293
-10.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#496
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $22,174,741 across 15 Diagnostics & Research names. NTRA ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
26,698 | $13,385,309 | |
| 2 | GRAL |
GRAIL, Inc.
|
19,753 | $1,348,537 | |
| 3 | GH |
Guardant Health, Inc.
|
7,149 | $1,072,564 | |
| 4 | ILMN |
Illumina, Inc.
|
5,708 | $1,003,637 | |
| 5 | DHR |
Danaher Corp /De/
|
5,081 | $967,828 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,651 | $869,152 | |
| 7 | A |
Agilent Technologies, Inc.
|
4,746 | $630,411 | |
| 8 | NTRA |
Natera, Inc.
This page
|
2,293 | $622,434 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $622,434 | 2,293 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $514,174 | 2,571 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $655,655 | 2,862 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $466,008 | 2,895 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||